Sildenafil Citrate
Product Images NDC 45865-937

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 45865-937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 01)

Chemical structure of Sildenafil Citrate showing its molecular framework with distinctive ring systems and functional groups, including pyrimidine and sulfonamide moieties.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 02)

A line graph showing mean change from baseline in sitting systolic blood pressure over 24 hours post-dose in healthy volunteers. It compares two groups: Sildenafil 100 mg and placebo, with systolic blood pressure in mmHg on the vertical axis and time post dose in hours on the horizontal axis.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 03)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' depicting changes in systolic blood pressure over 8 hours for two groups: one treated with Doxazosin plus placebo, and the other with Doxazosin plus Sildenafil 25 mg. The x-axis represents time postdose in hours, and the y-axis represents the change in systolic blood pressure in mmHg.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 04)

A line graph depicting the effect of Doxazosin compared to Placebo and Doxazosin with Sildenafil 50 mg on systolic blood pressure over time in hours postdose. The y-axis shows change in systolic blood pressure (mmHg), while the x-axis indicates time postdose (hours). Two data series are plotted using blue and black lines.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 05)

This line graph illustrates the mean standing systolic blood pressure change from baseline over 8 hours after dosing. It compares two groups: one receiving Doxazosin plus Sildenafil 100 mg and another receiving Doxazosin plus placebo. The y-axis represents change in mmHg, ranging from -50 to 4, while the x-axis shows time after dosing in hours, from 0 to 8.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 06)

A line graph showing mean plasma concentrations of Sildenafil over 24 hours in healthy male volunteers. The x-axis represents time post dose (hours), and the y-axis shows plasma concentration (ng/mL). A single line represents the commercial tablet treatment, indicating peak concentration followed by a gradual decline.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 07)

A bar chart displaying the percentage of patients at endpoint versus baseline score. The chart includes multiple data series labeled 0 through 5, with percentages shown on the y-axis and baseline scores on the x-axis. The highest bars appear in the series labeled 2 and 5 at higher baseline scores.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 08)

Bar chart depicting the percentage of patients at endpoint on the vertical axis versus baseline score on the horizontal axis. Different shades or patterns represent distinct categories or groups, numbered 0 through 5, indicating data distribution across baseline scores.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 09)

A vertical bar graph showing percentage of patients reporting improvement by treatment group for Sildenafil Citrate. Groups include Placebo, Sildenafil Citrate 25 mg, 50 mg, and 100 mg, with increasing percentages from approximately 24% for placebo to 82% for the 100 mg dose. The x-axis lists treatment groups and patient numbers, and the y-axis shows percentage improvement from 0 to 100%.*

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 10)

FDA Label Image

Image (716719c3 C2ab 40c8 A321 6f6ecc0a5315 11)

FDA Label Image

Pdp (937)

Sildenafil Citrate tablets 100 mg packaging label highlights the generic name Sildenafil, dosage strength 100 mg, and tablet form film-coated in blue and round shape. The label states it is a generic for Viagra, manufactured by Medsource Pharmaceuticals under the NDC 45865-0937. The label includes warnings about interactions with nitrates and cyclase stimulators and instructions to follow physician direction for dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.